These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 36831276)

  • 21. Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease.
    Francis C; Courbon G; Gerber C; Neuburg S; Wang X; Dussold C; Capella M; Qi L; Isakova T; Mehta R; Martin A; Wolf M; David V
    Kidney Int; 2019 Dec; 96(6):1346-1358. PubMed ID: 31668632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production.
    David V; Martin A; Isakova T; Spaulding C; Qi L; Ramirez V; Zumbrennen-Bullough KB; Sun CC; Lin HY; Babitt JL; Wolf M
    Kidney Int; 2016 Jan; 89(1):135-46. PubMed ID: 26535997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia.
    Agoro R; Montagna A; Goetz R; Aligbe O; Singh G; Coe LM; Mohammadi M; Rivella S; Sitara D
    FASEB J; 2018 Jul; 32(7):3752-3764. PubMed ID: 29481308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammation regulates fibroblast growth factor 23 production.
    Francis C; David V
    Curr Opin Nephrol Hypertens; 2016 Jul; 25(4):325-32. PubMed ID: 27191351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats.
    Leifheit-Nestler M; Grabner A; Hermann L; Richter B; Schmitz K; Fischer DC; Yanucil C; Faul C; Haffner D
    Nephrol Dial Transplant; 2017 Sep; 32(9):1493-1503. PubMed ID: 28339837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amelioration of chronic kidney disease-associated anemia by vadadustat in mice is not dependent on erythroferrone.
    Hanudel MR; Wong S; Jung G; Qiao B; Gabayan V; Zuk A; Ganz T
    Kidney Int; 2021 Jul; 100(1):79-89. PubMed ID: 33811979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FGF23 impairs peripheral microvascular function in renal failure.
    Verkaik M; Juni RP; van Loon EPM; van Poelgeest EM; Kwekkeboom RFJ; Gam Z; Richards WG; Ter Wee PM; Hoenderop JG; Eringa EC; Vervloet MG;
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1414-H1424. PubMed ID: 30028196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3.
    Shardlow A; McIntyre NJ; Fluck RJ; McIntyre CW; Taal MW
    BMJ Open; 2017 Aug; 7(8):e016528. PubMed ID: 28838895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The regulation of FGF23 under physiological and pathophysiological conditions.
    Rausch S; Föller M
    Pflugers Arch; 2022 Mar; 474(3):281-292. PubMed ID: 35084563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone and heart health in chronic kidney disease: role of dentin matrix protein 1.
    Martin A
    Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):297-303. PubMed ID: 31107286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Segregating the effects of ferric citrate-mediated iron utilization and FGF23 in a mouse model of CKD.
    Liesen MP; Noonan ML; Ni P; Agoro R; Hum JM; Clinkenbeard EL; Damrath JG; Wallace JM; Swallow EA; Allen MR; White KE
    Physiol Rep; 2022 Jun; 10(11):e15307. PubMed ID: 35656701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of ferric citrate clinical studies, and the rationale and design of the Ferric Citrate and Chronic Kidney Disease in Children (FIT4KiD) trial.
    Hanudel MR; Laster ML; Portale AA; Dokras A; Quigley RP; Guzman GAL; Zaritsky JJ; Hayde NA; Kaskel FJ; Mitsnefes MM; Ramirez JA; Imani PD; Srivaths PR; Kogon AJ; Denburg MR; Blydt-Hansen TD; Reyes LZ; Greenbaum LA; Weidemann DK; Warady BA; Elashoff DA; Mendley SR; Isakova T; Salusky IB
    Pediatr Nephrol; 2022 Nov; 37(11):2547-2557. PubMed ID: 35237863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased FGF23 protects against detrimental cardio-renal consequences during elevated blood phosphate in CKD.
    Clinkenbeard EL; Noonan ML; Thomas JC; Ni P; Hum JM; Aref M; Swallow EA; Moe SM; Allen MR; White KE
    JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of FGF23: Beyond Bone.
    Simic P; Babitt JL
    Curr Osteoporos Rep; 2021 Dec; 19(6):563-573. PubMed ID: 34757587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FGF23/FGFR4-mediated left ventricular hypertrophy is reversible.
    Grabner A; Schramm K; Silswal N; Hendrix M; Yanucil C; Czaya B; Singh S; Wolf M; Hermann S; Stypmann J; Di Marco GS; Brand M; Wacker MJ; Faul C
    Sci Rep; 2017 May; 7(1):1993. PubMed ID: 28512310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials.
    Zhao SJ; Wang ZX; Chen L; Wang FX; Kong LD
    Ann Palliat Med; 2022 Apr; 11(4):1264-1277. PubMed ID: 34775773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
    Koizumi M; Komaba H; Fukagawa M
    Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How FGF23 shapes multiple organs in chronic kidney disease.
    Leifheit-Nestler M; Haffner D
    Mol Cell Pediatr; 2021 Sep; 8(1):12. PubMed ID: 34536161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced renal α-Klotho expression in CKD patients and its effect on renal phosphate handling and vitamin D metabolism.
    Sakan H; Nakatani K; Asai O; Imura A; Tanaka T; Yoshimoto S; Iwamoto N; Kurumatani N; Iwano M; Nabeshima Y; Konishi N; Saito Y
    PLoS One; 2014; 9(1):e86301. PubMed ID: 24466013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibroblast Growth Factor 23 as Regulator of Vitamin D Metabolism.
    Nakatani S; Nakatani A; Mori K; Emoto M; Inaba M; Razzaque MS
    Adv Exp Med Biol; 2022; 1362():47-54. PubMed ID: 35288872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.